TABLE OF CONTENTS
1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET 21
1.4 MARKETS COVERED 23
2 MARKET SEGMENTATION 26
2.1 MARKETS COVERED 26
2.2 GEOGRAPHICAL SCOPE 27
2.3 YEARS CONSIDERED FOR THE STUDY 27
2.4 CURRENCY AND PRICING 27
2.5 DBMR TRIPOD DATA VALIDATION MODEL 28
2.6 MULTIVARIATE MODELLING 31
2.7 TYPE LIFELINE CURVE 31
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 32
2.9 DBMR MARKET POSITION GRID 33
2.10 MARKET APPLICATION COVERAGE GRID 34
2.11 VENDOR SHARE ANALYSIS 35
2.12 SECONDARY SOURCES 36
2.13 ASSUMPTIONS 36
3 EXECUTIVE SUMMARY 37
4 PREMIUM INSIGHTS 40
4.1 PESTEL ANALYSIS 41
4.2 PORTERS FIVE FORCES MODEL 42
5 INDUSTRIAL INSIGHTS 43
6 MARKET OVERVIEW 44
6.1 DRIVERS 46
6.1.1 RISING PREVALENCE RATE OF CONGENITAL FACIAL DEFORMITIES 46
6.1.2 INCREASE IN TRAUMA CASES AND ROAD ACCIDENTS 46
6.1.3 INCREASING DEMAND FOR FACIAL RECONSTRUCTION SURGERY 47
6.1.4 RECENT TECHNOLOGICAL ADVANCEMENTS IN CMF IMPLANTS 47
6.2 RESTRAINTS 48
6.2.1 HIGH COST OF SURGERIES AND IMPLANTS 48
6.2.2 IMPLANT MALFUNCTION AND ASSOCIATED RISK 49
6.2.3 LACK OF AWARENESS FOR CRANIOMAXILLOFACIAL SURGERY 49
6.3 OPPORTUNITIES 50
6.3.1 GROWING GERIATRIC POPULATION 50
6.3.2 RISE IN HEALTHCARE EXPENDITURE & INFRASTRUCTURE 50
6.3.3 GROWING R&D ACTIVITIES AND TECHNOLOGICAL ADVANCEMENT 51
6.3.4 INCREASE IN DEMAND FOR CUSTOMIZED AND PATIENT-SPECIFIC IMPLANTS 51
6.4 CHALLENGES 52
6.4.1 INCREASE IN PRODUCT RECALL 52
6.4.2 POST SURGERY COMPLIACTION 53
7 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE 54
7.1 OVERVIEW 55
7.2 BONE GRAFT SUBSTITUTE 58
7.2.1 NATURAL 58
7.2.2 SYNTHETIC 58
7.3 MID-FACE IMPLANTS 58
7.3.1 PLATES 59
7.3.2 SCREWS 59
7.4 CRANIAL/NEURO IMPLANTS 59
7.4.1 PLATES 60
7.4.2 SCREWS 60
7.4.3 CONTOURABLE MESHES 60
7.5 MANDIBULAR ORTHOGNATHIC IMPLANTS 60
7.5.1 PLATES 61
7.5.2 SCREWS 61
7.6 DISTRACTION SYSTEM 61
7.7 CRANIAL FLAP FIXATION SYSTEM 61
7.8 PATIENT SPECIFIC IMPLANTS (PSI) 62
7.8.1 METAL 62
7.8.2 PLASTIC 62
7.8.3 OTHERS 62
7.8.4 NORMAL 63
7.8.5 3D PRINTED 63
7.8.6 CAD 63
7.8.7 ADEPT SOFTWARE 63
7.8.8 CAM 64
7.8.9 OTHERS 64
7.9 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEM 64
7.10 DURAL REPAIR PRODUCTS 64
7.10.1 DURAL SEALANTS 65
7.10.2 DURAL SUBSTITUTES 65
7.11 OTHERS 65
8 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION 66
8.1 OVERVIEW 67
8.2 METALS 70
8.2.1 TITANIUM AND ALLOYS 71
8.2.2 STAINLESS STEEL 71
8.2.3 POLYETHERETHERKETONE (PEEK) 71
8.2.4 SILICON NITRIDE 71
8.2.5 OTHERS 71
8.3 BONE GRAFT SUBSTITUTE 71
8.4 POLYMERS/BIOMATERIAL 72
8.5 OTHERS 72
9 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE 73
9.1 OVERVIEW 74
9.2 INTERNAL FIXATORS 77
9.2.1 BONE GRAFT SUBSTITUTE 77
9.2.2 MID-FACE IMPLANTS 78
9.2.3 CRANIAL/NEURO IMPLANTS 78
9.2.4 MANDIBULAR ORTHOGNATHIC IMPLANTS 78
9.2.5 DISTRACTION SYSTEM 78
9.2.6 CRANIAL FLAP FIXATION SYSTEMS 78
9.2.7 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEMS 78
9.2.8 OTHERS 78
9.3 EXTERNAL FIXATORS 78
9.3.1 DISTRACTION SYSTEM 79
9.3.2 OTHERS 79
10 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE 80
10.1 OVERVIEW 81
10.2 RECONSTRUCTIVE SURGERY 84
10.2.1 BONE GRAFT SUBSTITUTE 84
10.2.2 MID-FACE IMPLANTS 84
10.2.3 CRANIAL/NEURO IMPLANTS 84
10.2.4 MANDIBULAR ORTHOGNATHIC IMPLANTS 85
10.2.5 DISTRACTION SYSTEM 85
10.2.6 CRANIAL FLAP FIXATION SYSTEMS 85
10.2.7 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEM 85
10.2.8 DURAL REPAIR PRODUCTS 85
10.2.9 OTHERS 85
10.3 TRAUMA SURGERIES 85
10.3.1 BONE GRAFT SUBSTITUTE 86
10.3.2 MID-FACE IMPLANTS 86
10.3.3 CRANIAL/NEURO IMPLANTS 86
10.3.4 MANDIBULAR ORTHOGNATHIC IMPLANTS 86
10.3.5 DISTRACTION SYSTEM 86
10.3.6 CRANIAL FLAP FIXATION SYSTEMS 87
10.3.7 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEM 87
10.3.8 DURAL REPAIR PRODUCTS 87
10.3.9 OTHERS 87
10.4 PLASTIC SURGERIES 87
10.4.1 MID-FACE IMPLANTS 88
10.4.2 MANDIBULAR ORTHOGNATHIC IMPLANTS 88
10.4.3 CRANIAL/NEURO IMPLANTS 88
10.4.4 DISTRACTION SYSTEM 88
10.4.5 CRANIAL FLAP FIXATION SYSTEMS 88
10.4.6 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEM 88
10.4.7 OTHERS 89
10.5 ORTHOGNATHIC SURGERIES 89
10.5.1 BONE GRAFT SUBSTITUTE 89
10.5.2 MANDIBULAR ORTHOGNATHIC IMPLANTS 90
10.5.3 DISTRACTION SYSTEM 90
10.5.4 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEM 90
10.5.5 OTHERS 90
10.6 DENTAL SURGERIES 90
10.6.1 DISTRACTION SYSTEM 91
10.6.2 OTHERS 91
10.7 ENT SURGERIES 91
10.7.1 BONE GRAFT SUBSTITUTE 92
10.7.2 MID-FACE IMPLANTS 92
10.7.3 OTHERS 92
10.8 OTHERS 92
11 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY PROPERTY TYPE 93
11.1 OVERVIEW 94
11.2 NON-RESORBABLE FIXATORS 96
11.3 RESORBABLE FIXATORS 97
12 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER 98
12.1 OVERVIEW 99
12.2 HOSPITAL 101
12.3 SPECIALTY CLINICS 102
12.4 TRAUMA CENTERS 102
12.5 AMBULATORY SURGICAL CENTERS (ASCS) 102
12.6 OTHERS 103
13 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL 104
13.1 OVERVIEW 105
13.2 DIRECT TENDER 108
13.3 RETAIL SALES 108
14 MIDDLE EAST AND AFRICA 109
14.1 SAUDI ARABIA 115
14.2 SOUTH AFRICA 122
14.3 U.A.E. 129
14.4 ISRAEL 136
14.5 EGYPT 143
14.6 REST OF MIDDLE EAST AND AFRICA 150
15 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: COMPANY LANDSCAPE 151
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA 151
16 SWOT ANALYSIS 152
17 COMPANY PROFILE 153
17.1 ZIMMER BIOMET 153
17.1.1 COMPANY SNAPSHOT 153
17.1.2 REVENUE ANALYSIS 153
17.1.3 RODUCT PORTFOLIO 154
17.1.4 RECENT DEVELOPMENT 154
17.2 MEDTRONIC 155
17.2.1 COMPANY SNAPSHOT 155
17.2.2 REVENUE ANALYSIS 155
17.2.3 PRODUCT PORTFOLIO 156
17.2.4 RECENT DEVELOPMENT 156
17.3 DEPUY SYNTHES 157
17.3.1 COMPANY SNAPSHOT 157
17.3.2 REVENUE ANALYSIS 157
17.3.3 PRODUCT PORTFOLIO 158
17.3.4 RECENT DEVELOPMENT 158
17.4 STRYKER 159
17.4.1 COMPANY SNAPSHOT 159
17.4.2 REVENUE ANALYSIS 159
17.4.3 PRODUCT PORTFOLIO 160
17.4.4 RECENT DEVELOPMENTS 160
17.5 KLS-MARTIN GROUP 161
17.5.1 COMPANY SNAPSHOT 161
17.5.2 PRODUCT PORTFOLIO 161
17.5.3 RECENT DEVELOPMENT 162
17.6 ADVIN HEALTH CARE 163
17.6.1 COMPANY SNAPSHOT 163
17.6.2 PRODUCT PORTFOLIO 163
17.6.3 RECENT DEVELOPMENT 163
17.7 ANATOMICS PTY LTD. 164
17.7.1 COMPANY SNAPSHOT 164
17.7.2 PRODUCT PORTFOLIO 164
17.7.3 RECENT DEVELOPMENTS 164
17.8 BIOPLATE INC. 165
17.8.1 COMPANY SNAPSHOT 165
17.8.2 PRODUCT PORTFOLIO 165
17.8.3 RECENT DEVELOPMENT 165
17.9 DIMEDA INSTRUMENTE GMBH 166
17.9.1 COMPANY SNAPSHOT 166
17.9.2 PRODUCT PORTFOLIO 166
17.9.3 RECENT DEVELOPMENTS 166
17.10 INNOVASIS INC. 167
17.10.1 COMPANY SNAPSHOT 167
17.10.2 PRODUCT PORTFOLIO 167
17.10.3 RECENT DEVELOPMENT 167
17.11 JEIL MEDICAL CORPORATION 168
17.11.1 COMPANY SNAPSHOT 168
17.11.2 PRODUCT PORTFOLIO 168
17.11.3 RECENT DEVELOPMENT 168
17.12 PORIFEROUS 169
17.12.1 COMPANY SNAPSHOT 169
17.12.2 PRODUCT PORTFOLIO 169
17.12.3 RECENT DEVELOPMENT 169
17.12.4 MANUFACTURING CERTIFICATION 169
17.13 TEKNIMED 170
17.13.1 COMPANY SNAPSHOT 170
17.13.2 PRODUCT PORTFOLIO 170
17.13.3 RECENT DEVELOPMENT 170
17.13.4 MDSAP CERTIFICATION 170
17.14 XILLOC MEDICAL BV 171
17.14.1 COMPANY SNAPSHOT 171
17.14.2 PRODUCT PORTFOLIO 171
17.14.3 RECENT DEVELOPMENT 172
18 QUESTIONNAIRE 173
19 RELATED REPORTS 177

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.